IC View
The last IC recommendation on Allergy Therapeutics PLC shares was Hold at 13.00 on 25 Sep 2019Read the full article
- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Appointment of Non-Executive Director
- Progression of patient cohorts in PROTECT Trial
- Successful meetings with Paul Ehrlich Institut
- Allergy Therapeutics presents findings at EAACI
- Further detail from G306 Phase III field trial
- Director Resignation
- Interim Results for six months ended 31 Dec 2023
- Update on funding
- VLP Peanut PROTECT Trial Update
- VLP Peanut PROTECT Trial Update
More ▼
Key statistics
On Friday, Allergy Therapeutics PLC (AGY:LSE) closed at 5.24, -16.83% below its 52-week high of 6.30, set on Jun 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.15 |
---|---|
High | 5.24 |
Low | 5.24 |
Bid | 4.50 |
Offer | 5.50 |
Previous close | 5.15 |
Average volume | 678.39k |
---|---|
Shares outstanding | 4.77bn |
Free float | 323.44m |
P/E (TTM) | -- |
Market cap | 245.47m GBP |
EPS (TTM) | -0.0266 GBP |
Data delayed at least 20 minutes, as of Jun 28 2024 16:35 BST.
More ▼